Schizophrenia Clinical Trial
— CTI-TS RCTOfficial title:
A Pilot Multi-center Randomized Controlled Trial of Critical Time Intervention - Task Shifting (CTI-TS) Versus Usual Care for People With Psychotic Disorders
Verified date | June 2020 |
Source | Columbia University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The study represents the research component of a broader initiative entitled "RedeAmericas".
RedeAmericas (RA) is a collaborative effort of investigators from six cities across Latin
America (Buenos Aires, Cordoba, Medellin, Neuquen, Rio de Janeiro, and Santiago) and Columbia
University in New York.
This is a pilot Randomized Controlled Trial (RCT) of Critical Time Intervention—Task Shifting
(CTI-TS). It is designed to address a fundamental gap in the services offered by mental
health clinics. These clinics are the primary locale for outpatient treatment of individuals
with severe mental disorders in the urban areas of Latin America, and they offer some basic
and important clinical care such as pharmacologic treatment onsite. Generally these clinics
also have a major limitation; they have inadequate resources and training for the provision
of in vivo community-based services, that is, services delivered outside of the clinic
facility in homes or elsewhere in the community. In most urban areas, they also have weak
links to primary health care and are not easily accessible to much of the population.
CTI-TS, is a task shifting intervention that at the service user level provides support for
better community living and promotes social integration, and at the system level strengthens
the connections between mental health and primary care clinics. CTI-TS is a time-limited
9-month intervention provided at the critical time when a person is first offered services at
a mental health clinic. During this period CTI-TS workers forge relationships that will shape
the continuing use of services and enhance the potential for recovery over the subsequent
course of time. The overall goal of CTI-TS is to improve the lives of those with severe
mental disorders who receive community-based mental health care.
Status | Completed |
Enrollment | 110 |
Est. completion date | June 1, 2020 |
Est. primary completion date | June 1, 2020 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 21 Years to 65 Years |
Eligibility |
Inclusion Criteria: - 21-65 years of age. - No longer than 6 months since the first visit to the MHS (excluding visits that took place more than one year ago). - Any psychotic disorder (chart diagnosis) from the following groups (ICD-10 criteria): F20-29 including schizophrenia, delusional disorders, schizotypal disorders, acute polymorph psychotic disorders, schizoaffective disorders F30-39 the following mood [affective] disorders with psychoses: F30.2 Mania with psychotic symptoms F31.2 Bipolar affective disorder, current episode manic with psychotic symptoms F31.5 Bipolar affective disorder, current episode severe depression with psychotic symptoms F32.3 Severe depressive episode with psychotic symptoms F33.3 Recurrent depressive disorder, current episode severe with psychotic symptom Exclusion Criteria: - Under age 21 or over age 65. - Active suicidal ideation. - Substance Abuse or Dependence alone (may have psychotic symptoms but does not meet criteria for diagnoses included). - Serious cognitive or other sensorial impairment which is likely to preclude reliable assessment via our interview procedures. |
Country | Name | City | State |
---|---|---|---|
Brazil | Federal University of Rio de Janeiro | Rio de Janeiro | |
Chile | University of Chile | Santiago |
Lead Sponsor | Collaborator |
---|---|
Columbia University | National Institute of Mental Health (NIMH) |
Brazil, Chile,
Agrest M, Le PD, Yang LH, Mascayano F, Alves-Nishioka S, Dev S, Kankan T, Tapia-Muñoz T, Sawyer S, Toso-Salman J, Dishy GA, Jorquera MJ, Schilling S, Pratt C, Price L, Valencia E, Conover S, Alvarado R, Susser ES. Implementing a community-based task-shifting psychosocial intervention for individuals with psychosis in Chile: Perspectives from users. Int J Soc Psychiatry. 2019 Feb;65(1):38-45. doi: 10.1177/0020764018815204. — View Citation
Baumgartner JN, da Silva TF, Valencia E, Susser E. Measuring social integration in a pilot randomized controlled trial of critical time: intervention-task shifting in Latin America. Cad Saude Colet. 2012 Jan;20(4). doi: 10.1590/S1414-462X2012000400005. — View Citation
Baumgartner JN, Susser E. Social integration in global mental health: what is it and how can it be measured? Epidemiol Psychiatr Sci. 2013 Mar;22(1):29-37. doi: 10.1017/S2045796012000303. Epub 2012 May 25. — View Citation
Herman D, Opler L, Felix A, Valencia E, Wyatt RJ, Susser E. A critical time intervention with mentally ill homeless men: impact on psychiatric symptoms. J Nerv Ment Dis. 2000 Mar;188(3):135-40. — View Citation
Herman DB, Conover S, Gorroochurn P, Hinterland K, Hoepner L, Susser ES. Randomized trial of critical time intervention to prevent homelessness after hospital discharge. Psychiatr Serv. 2011 Jul;62(7):713-9. doi: 10.1176/ps.62.7.pss6207_0713. — View Citation
Jones K, Colson PW, Holter MC, Lin S, Valencia E, Susser E, Wyatt RJ. Cost-effectiveness of critical time intervention to reduce homelessness among persons with mental illness. Psychiatr Serv. 2003 Jun;54(6):884-90. — View Citation
Mascayano F, Alvarado R, Andrews HF, Jorquera MJ, Lovisi GM, Souza FM, Pratt C, Rojas G, Restrepo-Toro ME, Fader K, Gorroochurn P, Galea S, Dahl CM, Cintra J, Conover S, Burrone MS, Baumgartner JN, Rosenheck R, Schilling S, Sarução KR, Stastny P, Tapia E, Cavalcanti MT, Valencia E, Yang LH, Susser E. Implementing the protocol of a pilot randomized controlled trial for the recovery-oriented intervention to people with psychoses in two Latin American cities. Cad Saude Publica. 2019 May 2;35(4):e00108018. doi: 10.1590/0102-311X00108018. — View Citation
Minoletti A, Galea S, Susser E. Community mental health services in Latin America. Public Health Reviews, 34(2):1-23, 2013.
Susser E, Valencia E, Conover S, Felix A, Tsai WY, Wyatt RJ. Preventing recurrent homelessness among mentally ill men: a "critical time" intervention after discharge from a shelter. Am J Public Health. 1997 Feb;87(2):256-62. — View Citation
Yang L, Pratt C, Valencia E, Conover S, Fernández R, Burrone MS, Cavalcanti MT, Lovisi G, Rojas G, Alvarado R, Galea S, Price LN, Susser E. RedeAmericas: building research capacity in young leaders for sustainable growth in community mental health services in Latin America. Glob Ment Health (Camb). 2017 Feb 14;4:e3. doi: 10.1017/gmh.2017.2. eCollection 2017. — View Citation
Yang LH, Valencia E, Alvarado R, Link B, Huynh N, Nguyen K, Morita K, Saavedra M, Wong C, Galea S, Susser E. A theoretical and empirical framework for constructing culture-specific stigma instruments for Chile. Cad Saude Colet. 2013;21(1):71-79. — View Citation
* Note: There are 11 references in all — Click here to view all references
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Camberwell Assessment of Need (CAN) | Used to assess the needs of people with severe mental illness. | 18 months | |
Primary | World Health Organization Quality of Life, Short Form (WHOQOL-BREF) | Used to provide a quality of life measurement. | 18 months | |
Secondary | World Health Organization Disability Assessment Schedule II (WHODAS 2.0) | Measures level of disability | 18 months | |
Secondary | Recovery Assessment Scale (RAS) | Assessment tool to measure factors important to recovery | 18 months | |
Secondary | Continuity of care and course of illness | CONNECT, a measure of continuity of care, and the Life Chart Schedule are used. | 18 months | |
Secondary | Perceived stigma | Perceived Discrimination and Devaluation Scale (PDD) is used for this outcome | 18 months | |
Secondary | Self-stigma | Internalized stigma of mental illness (ISMI) is the measure used. | 18 months | |
Secondary | Substance use | ASSIST, the WHO Alcohol, Smoking and Substance Involvement Screening Test is used for this measure. | 18 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05039489 -
A Study on the Brain Mechanism of cTBS in Improving Medication-resistant Auditory Hallucinations in Schizophrenia
|
N/A | |
Completed |
NCT05111548 -
Brain Stimulation and Cognitive Training - Efficacy
|
N/A | |
Completed |
NCT05321602 -
Study to Evaluate the PK Profiles of LY03010 in Patients With Schizophrenia or Schizoaffective Disorder
|
Phase 1 | |
Completed |
NCT04503954 -
Efficacy of Chronic Disease Self-management Program in People With Schizophrenia
|
N/A | |
Completed |
NCT02831231 -
Pilot Study Comparing Effects of Xanomeline Alone to Xanomeline Plus Trospium
|
Phase 1 | |
Completed |
NCT05517460 -
The Efficacy of Auricular Acupressure on Improving Constipation Among Residents in Community Rehabilitation Center
|
N/A | |
Completed |
NCT03652974 -
Disturbance of Plasma Cytokine Parameters in Clozapine-Resistant Treatment-Refractory Schizophrenia (CTRS) and Their Association With Combination Therapy
|
Phase 4 | |
Recruiting |
NCT04012684 -
rTMS on Mismatch Negativity of Schizophrenia
|
N/A | |
Recruiting |
NCT04481217 -
Cognitive Factors Mediating the Relationship Between Childhood Trauma and Auditory Hallucinations in Schizophrenia
|
N/A | |
Completed |
NCT00212784 -
Efficacy and Safety of Asenapine Using an Active Control in Subjects With Schizophrenia or Schizoaffective Disorder (25517)(P05935)
|
Phase 3 | |
Completed |
NCT04092686 -
A Clinical Trial That Will Study the Efficacy and Safety of an Investigational Drug in Acutely Psychotic People With Schizophrenia
|
Phase 3 | |
Completed |
NCT01914393 -
Pediatric Open-Label Extension Study
|
Phase 3 | |
Recruiting |
NCT03790345 -
Vitamin B6 and B12 in the Treatment of Movement Disorders Induced by Antipsychotics
|
Phase 2/Phase 3 | |
Recruiting |
NCT05956327 -
Insight Into Hippocampal Neuroplasticity in Schizophrenia by Investigating Molecular Pathways During Physical Training
|
N/A | |
Terminated |
NCT03209778 -
Involuntary Memories Investigation in Schizophrenia
|
N/A | |
Terminated |
NCT03261817 -
A Controlled Study With Remote Web-based Adapted Physical Activity (e-APA) in Psychotic Disorders
|
N/A | |
Completed |
NCT02905604 -
Magnetic Stimulation of the Brain in Schizophrenia or Depression
|
N/A | |
Recruiting |
NCT05542212 -
Intra-cortical Inhibition and Cognitive Deficits in Schizophrenia
|
N/A | |
Completed |
NCT04411979 -
Effects of 12 Weeks Walking on Cognitive Function in Schizophrenia
|
N/A | |
Terminated |
NCT03220438 -
TMS Enhancement of Visual Plasticity in Schizophrenia
|
N/A |